Minneapolis, MN, (December 23, 2013) –Yukon Partners (“Yukon”) is pleased to announce its mezzanine capital and equity investment in Accelecare Wound Centers (“Accelecare”).
Accelecare, headquartered in Bellevue, Washington, is a comprehensive wound care and disease management company. The company provides full service wound management solutions to hospitals and related health care organizations across the United States.
Revelstoke Capital Partners (“Revelstoke”) sponsored the transaction in which it, Yukon and seven other institutional co-investors acquired a majority equity interest in Accelecare. Mezzanine capital was provided by Yukon, The Northwestern Mutual Life Insurance Company, and Nationwide Mutual Insurance Company. The senior credit facility was Agented and underwritten by Ally Commercial Finance. Ally received commitments from Fifth Third Bank and Siemens Financial Services, Inc. to round out the senior financing.
Revelstoke will provide Accelecare strategic guidance and additional capital to accelerate its organic growth, pursue selective acquisitions, and continue to leverage its scalable business model for continued growth.
“The resources and expertise that Revelstoke bring to our team allows us to continue our focus on growth while maintaining the quality and efficacy of our services,” said Michael Lester, CEO of Accelecare.
“We are excited about the prospects of working with an extremely talented and experienced management team to continue to grow the Company and further solidify its position as a leader in the wound care industry,” noted Mark King, CEO, Managing Partner and Co-Founder of Revelstoke. “We are very pleased to have closed this transaction within 56 days of signing an exclusive letter of intent. Yukon played an invaluable role in supporting Revelstoke and Accelecare.”
“We are excited to be partnering with Revelstoke and the senior leadership team of Accelecare to continue the Company’s impressive track record of growth and operational excellence,” said Michael Hall, Managing Partner of Yukon.
Bain Capital Ventures, SV Life Sciences, River Cities Capital Fund, and management will continue to own a meaningful portion of Accelecare.
Accelecare (www.accelecare.com) partners with hospitals and skilled nursing facilities to provide advanced wound care services across the United States. The company is currently comprised of more than 120 state of the art Advanced Wound Centers staffed with trained physicians, nurses, and specialized technicians that provide efficacious and cost effective wound treatments.
Yukon Partners (www.yukonpartners.com) is a mezzanine finance firm dedicated to serving middle market private equity sponsored business transactions with a typical investment range of $10 to $40 million in the U.S. and Canada. The transactions in which Yukon invests include Buyouts, Growth and Platform Strategies, Recapitalizations, Mergers/Acquisitions, and Public to Private Buyouts. Yukon Partners is based in Minneapolis, Minnesota.
Revelstoke (www.revelstokecp.com) is a private equity firm formed by experienced investors who strive to partner with management teams to execute on a disciplined organic and acquisition strategy to build industry-leading companies.
Revelstoke ’s Managing Partners, Mark King, Dale Meyer, and Simon Bachleda, have completed over 100 platform and add-on acquisitions, representing over $5 billion of total enterprise value.
For more information, please contact: